I am involved in clinical research in breast cancer including clinical trials focused on all stages of disease. Much of my research involved incorporating state-of-the-art imaging methods into clinical trials involving novel therapies and companion circulating and tissue biomarkers. Current interests include biomarker discovery including the use of functional imaging for predicting breast cancer risk and response to antitumor therapies. My work also focuses on understanding the tumor microenvironment and characterizing circulating biomarkers for disease prognosis and targeted therapies.